GSK plc (LSE/NYSE: GSK) and the University of Oxford (Oxford) today announced that they have entered a new research ...

PALO ALTO, CALIFORNIA / ACCESS Newswire / January 27, 2025 / Bioz, Inc., a pioneer in AI-driven tools for scientific discovery, is transforming the way scientists discover and evaluate scientific ...

Thermo Fisher Scientific, the world leader in serving science, today announced the introduction of Olink® Reveal, setting a new standard for affordable, high-plex proteomics that enables researchers t ...

Pfizer Inc. (NYSE: PFE) today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX® ) and mFOLFOX6 ...

Moderna, Inc. (NASDAQ:MRNA) today announced that it has been awarded a tender for the supply of its mRNA COVID-19 vaccine in the European Union (EU), Norway and North Macedonia. Under the resulting ...

Novo Nordisk today announced topline results from a phase 1b/2a clinical trial with amycretin, a unimolecular GLP-1 and amylin receptor agonist intended for once weekly subcutaneous administration.

GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix (GSK’s Recombinant ...

Original-Research: Cantourage Group SE - from NuWays AG27.01.2025 / 09:00 CET/CESTDissemination of a Research, transmitted by EQS News - a service of EQS Group.The issuer is solely responsible for the ...

In-Depth Technical Insights Supporting the Enhanced KPIs for Trusted Results TAMPA, FLORIDA / ACCESS Newswire / January 26, 2025 / Black Book™ has developed eighteen enhanced Key Performance ...

CEO and biomedical engineer George K. Lewis will discuss the clinical effectiveness of sustained acoustic medicine in ...

TAMPA, FLORIDA / ACCESS Newswire / January 25, 2025 / Black Book Market Research LLC announces the release of the 2025 Black Book of Healthcare Cybersecurity, an extensive and meticulously curated LLM ...

CLASS data FOR NOVEL APPROACH TO CANCER treatmentParsortix system used to identify patients with highly metastatic CTC clusters for targeted treatmentNew treatment strategy provides 'uncharted ...